Horizon is a biopharmaceutical company focused on researching, developing and commercializing medicines that address critical needs for people impacted by rare and rheumatic diseases. Our pipeline is purposeful: we apply scientific expertise and courage to bring clinically meaningful therapies to patients. We believe science and compassion must work together to transform lives.
Horizon's global headquarters is in Dublin, Ireland. The Company also has offices in Lake Forest, Ill.; Chicago, Ill.; Brisbane, Calif.; Novato, Calif.; Washington, D.C. and Mannheim, Germany.
Copyright West LLC. Minimum 15 minutes delayed.
Apr 2, 2020 at 8:00 AM EDT
Horizon Acquisition of Curzion (4/2/20)
Mar 3, 2020 at 12:00 PM EST
Cowen and Company 40th Annual Health Care Conference
Feb 26, 2020 at 8:00 AM EST
Horizon Therapeutics Fourth Quarter 2019 Earnings Call
Jan 21, 2020 at 5:00 PM EST
FDA Approval of Teprotumumab/TEPEZZA™
Jan 15, 2020 at 5:30 PM PST
38th Annual J.P. Morgan Healthcare Conference - Q&A